The Centers for Medicare & Medicaid Services is changing how states select candidates for the Special Focus Facility Program ...

The Centers for Medicare & Medicaid Services (CMS) issued a revised memo Wednesday to strengthen the Special Focus Facility ...

Veradermics is set to raise $200 million in an IPO to fund its novel extended-release oral minoxidil for pattern hair loss.

Dr. Michael Antil left the U.S. in 2023 with his family, driven out by an increasingly conservative political climate and COVID-era hostility toward doctors. Now a family physician to over 2,000 ...

Cash-rich Cullinan Therapeutics stock: zipalertinib NDA in Q1 2026 plus CLN-978 and CLN-049 AML catalysts. Read here for more analysis.

The SNF Value-Based Purchasing Program is shifting from a single readmission-focused metric to a broader evaluation of SNF performance.

This article is sponsored by WellSky. As long-term care providers face tighter staffing, heavier documentation loads, and ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...

Lazard Ltd (NYSE:LAZ) Q4 2025 Earnings Call Transcript January 29, 2026 Lazard Ltd beats earnings expectations. Reported EPS ...

Detailed price information for Dyne Therapeutics Inc (DYN-Q) from The Globe and Mail including charting and trades.

According to results from the IMerge trial, 2 39.8% of patients treated with imetelstat achieved 8 weeks of transfusion independence compared with 15.0% of patients treated with placebo. Respondents ...

MDS is a group of conditions that affect new blood cell production. With MDS, blood cells in the bone marrow are abnormal, which leads to fewer healthy red blood cells, white blood cells, and ...